Loading
A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting.
Effects of Digital Therapeutic in Whole Process Management of Lung Cancer is a phase 3, randomised interventional study registered as NCT06230445 by Sun Yat-sen University, with a registry enrolment figure of 900 participants, started 2023-06-01 and due to reach its primary completion in 2026-03-01. Interventions recorded: UHealth digital therapeutic. Conditions listed: Application of Digital Therapeutic in Lung Cancer Whole Process Management. Primary outcome: The quality of life after 6 months follow-up. Lung eligibility wording from the registry: "* Patients with histologically or cytologically confirmed lung cancer;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.